QGEN : Summary for Qiagen N.V. - Yahoo Finance

U.S. Markets closed


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
27.80+0.16 (+0.58%)
At close: 4:00PM EST

27.80 0.00 (0.01%)
After hours: 5:19PM EST

People also watch
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
Previous Close27.64
Bid24.65 x 400
Ask28.00 x 100
Day's Range27.72 - 27.89
52 Week Range19.94 - 28.98
Avg. Volume915,077
Market Cap6.66B
PE Ratio (TTM)55.60
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Better Buy: Opko Health, Inc. vs. Qiagen
    Motley Fool4 days ago

    Better Buy: Opko Health, Inc. vs. Qiagen

    Does Opko Health's recent clinical setback hurt it in a head-to-head comparison with Qiagen? Or does it actually help?

  • QIAGEN NV – Value Analysis (NASDAQ:QGEN) : January 19, 2017
    Capital Cube4 days ago

    QIAGEN NV – Value Analysis (NASDAQ:QGEN) : January 19, 2017

    Categories: Fundamental Analysis Yahoo Finance Click here to see latest analysis Capitalcube gives QIAGEN NV a score of 56. Our analysis is based on comparing QIAGEN NV with the following peers – Thermo Fisher Scientific Inc., Genomic Health, Inc., Hologic, Inc., Becton, Dickinson and Company, General Electric Company, Trovagene, Inc., Bio-Techne Corporation and GenMark Diagnostics, Inc. (TMO-US, GHDX-US, HOLX-US, BDX-US, ... Read more (Read more...)

  • PR Newswire5 days ago

    QIAGEN Announces Details for Completion of Approximately $250 Million Synthetic Share Repurchase

    VENLO, The Netherlands, January 18, 2017 /PRNewswire/ -- QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) (the "Company") today announced details for completion of a synthetic share ...